Bio-Path Holdings, Inc. (BPTH) Social Stream
BIO-PATH HOLDINGS INC (BPTH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BPTH.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-03-14 | 1 | $13 | $12 | $12.5 | $0.53 | 2258.49% |
2022-05-17 | 2 | $13 | $12 | $12.5 | $0.53 | 2258.49% |
2023-03-17 | 2 | $13 | $9 | $11 | $0.53 | 1975.47% |
2023-05-12 | 1 | $13 | $13 | $13 | $0.53 | 2352.83% |
2023-11-15 | 1 | $12 | $12 | $12 | $0.53 | 2164.15% |
Price Target Last Issued May 12, 2023
The Trend in the Analyst Price Target
BPTH's average price target has moved down $0.5 over the prior 26 months.
BPTH reports an average of 1,422.38% for its upside potential over the past 35 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-03-17 | 2 | 13 | 13 | 13 | 1.560 | 733.33% |
2023-03-17 | 2 | 13 | 9 | 11 | 1.560 | 605.13% |
2023-05-12 | 1 | 13 | 13 | 13 | 1.480 | 778.38% |
2023-08-10 | 1 | 12 | 12 | 12 | 0.427 | 2710.3% |
2023-11-15 | 1 | 12 | 12 | 12 | 0.534 | 2147.19% |
BPTH Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 18 months, BPTH's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BPTH as an investment opportunity.
- BIO-PATH HOLDINGS INC's number of analysts covering the stock is higher than 5.66% of all US stocks.
- BPTH has a greater upside potential (average analyst target price relative to current price) than 593.52% of all US stocks.
- BIO-PATH HOLDINGS INC's variance in analysts' estimates is lower than 48.14% of Pharmaceutical Products stocks.
- In terms of how BIO-PATH HOLDINGS INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 127.13% of that group.
Stocks similar to BIO-PATH HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ONTX, ADXS, and NWBO.
View All Top Stocks by Price Target
Make investment decisions regarding BPTH using the data that counts. Try POWR Ratings for free.